|ECR 2011 / C-1595|
|Usefulness of MRI for evaluation of neoadjuvant chemotherapy effectiveness and preoperative staging of cervical cancer|
Uterine cervical cancer is the third most common gynaecological malignancy after endometrial and ovarian cancers. Standard treatment for patients with locally advanced cervical cancer is chemoradiotherapy.
MRI is the imaging modality of choice for preoperative staging and follow-up in patients with cervical cancer. The purpose of this study was to investigate diagnostic capabilities of MRI for evaluation of effectiveness of neoadjuvant chemotherapy (NACT) with uterine arteries chemoembolization (UACE) and for preoperative staging of cervical cancer.
Thematically related posters
ECR 2011 / C-1548
New FIGO Staging of Uterine malignancies with MR Imaging: Correlation with Surgical and Histopathologic Findings